Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ

OBJECTIVE: Since dermatomyositis (DM) is associated with an increased risk of malignancy, accurate identification of patients likely to harbor cancers is important. Using immunoprecipitations from radiolabeled cell lysates, several groups recently showed that anti–transcription intermediary factor 1...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Fiorentino, David F., Chung, Lorinda S., Christopher-Stine, Lisa, Zaba, Lisa, Li, Shufeng, Mammen, Andrew L., Rosen, Antony, Casciola-Rosen, Livia
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4073292/
https://ncbi.nlm.nih.gov/pubmed/24037894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.38093
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak